Scientific article
OA Policy
English

Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial

Published inClinical Infectious Diseases, vol. 68, no. 7, p. 1213-1222
Publication date2019
Abstract

Protection induced by acellular pertussis (aP) vaccines is partial and short-lived, especially in teenagers, calling for novel immunization strategies.

Keywords
  • Adhesins, Bacterial/genetics/immunology
  • Adolescent
  • Antibodies, Bacterial/blood
  • Antibodies, Neutralizing/blood
  • Antitoxins/blood
  • B-Lymphocyte Subsets/immunology
  • Child
  • Female
  • Humans
  • Immunization, Secondary/methods
  • Immunologic Memory
  • Male
  • Pertussis Toxin/genetics/immunology
  • Pertussis Vaccine/administration & dosage/immunology
  • Switzerland
  • Vaccines, Acellular/administration & dosage/immunology
  • Vaccines, Synthetic/administration & dosage/immunology
  • Virulence Factors, Bordetella/genetics/immunology
  • Whooping Cough/prevention & control
Citation (ISO format)
BLANCHARD ROHNER, Géraldine et al. Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial. In: Clinical Infectious Diseases, 2019, vol. 68, n° 7, p. 1213–1222. doi: 10.1093/cid/ciy594
Main files (2)
Article (Published version)
accessLevelRestricted
Article (Accepted version)
accessLevelPublic
Secondary files (1)
Appendix
accessLevelRestricted
Identifiers
Journal ISSN1058-4838
328views
379downloads

Technical informations

Creation16/10/2020 17:38:00
First validation16/10/2020 17:38:00
Update15/03/2023 22:59:49
Status update15/03/2023 22:59:47
Last indexation31/10/2024 20:15:54
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack